Abstract:Objective To explore the clinical outcome of percutaneous microwave/radiofrequency ablation liver partition and portal vein embolization for planned hepatectomy (PAPEP) for the treatment of hepatocelullar carcinoma (HCC) with insufficient future liver remnant (FLR).Methods The retrospective descriptive research method was taken.The clinical data of 2 patients of giant primary HCC (FLR complicated with cirrhosis) who were admitted to the Zhejiang Province People's Hospital from November 2015 to January 2016 were collected.Treatment plan:ultrasound-guided percutaneous microwave ablation (PMA) or percutaneous radio-frequency ablation (PRA) was performed on patients under intravenous anesthesia,at the same time portal vein embolization (PVE) was conducted.FLR was measured by rescan of computed tomography (CT) at 7-9 days postoperatively,according to FLR hyperplasia and general situation of the patient,right trisegmentectomy and expanded right hemihepatectomy were implemented respectively.Observation indicatiors indicators included (1)standard liver volume (SLV) and FLR before PRA/PVE treatment,(2) liver function,body temperature,FLR and time of FLR hyperplasia after PRA/PVE treatment,(3)liver function,body temperature,complications,FLR and duration of hospital stay after hepatectomy.Follow-up using outpatient examination and telephone interview was performed to detect carcinoma recurrence and other follow-up contents up to March 2016.Results (1) Before PRA + PVE,SLVs of 2 patients were 1 103 mL and 1 132mL,FLRs of 2 patients were respectively 417 mL and 297 mL which occupied the SLV at the percentage of 37.8％ and 26.2％ respectively.(2) After PRA + PVE treatment,there were no changes in liver function and fever.After PRA + PVE treatment,FLR of 2 patients increased to 652 mLand 522 mL,respectively,which occupied the SLV at the percentage of 59.1％ and 46.1％ respectively,with increased rates of 56.4％ and 75.6％ and time of FLR hyperplasia of 10 days and 17 days.The two patients received successful hepatectomy,without intraoperative red blood cell infusion.(3) At postoperative day 3,albumin (Alb),alanine transaminase (ALT),aspartate transaminase (AST) and total bilirubin (TBil) of liver function were 28.0 g/L,63 U/L,39 U/L and 19.0 μmol/L in patient 1 with a temperature of 38 degree,and 24.3 g/L,78 U/L,11 U/L and 38.1 μmol/L in patient 2 with a normal temperature.Liver function of 2 patients was improved after conservative treatment.No severe complications were occurred.Rescan of CT showed the FLR of patients continued increasing.The duration of hospital stay of 2 patients was 10 days and 14 days,respectively.Conclusion PAPEP for HCC with insufficient FLR is safe and effective.

Radiation Lobectomy in Adjunct to Double Vein Embolization to Reach Sufficient Future Liver Remnant in Patients with Colorectal Cancer Liver Metastases: A Case Series

[Percutaneous Microwave/Radiofrequency Ablation Liver Partition and Portal Vein Embolization for Planned Hepatectomy for Colorectal Liver Metastases with Insufficient Future Liver Remnant].

The Paradigm of Tumor Shrinkage and Rapid Liver Remnant Hypertrophy for Conversion of Initially Unresectable Colorectal Liver Metastasis: a Case Report and Literature Review

Efficacy of conversion therapy on future liver remnant hypertrophy for initially unresectable colorectal liver metastases: a review of current status and perspectives

Modified Radiation Lobectomy Strategy of Radioembolization for Right-Sided Unresectable Primary Liver Tumors

Dealing with an insufficient future liver remnant: Portal vein embolization and two‐stage hepatectomy

Extended Right Hepatectomy following Clearance of the Left Liver Lobe and Portal Vein Embolization for Curatively Intended Treatment of Extensive Bilobar Colorectal Liver Metastases: A Single-Center Case Series

Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection

Right portal vein ligation is still relevant for left hemi-liver hypertrophy: results of a comparative study using a propensity score between right portal vein ligation and embolization

Combining Radiofrequency Ablation with Hepatic Resection for Liver-Only Colorectal Metastases: A Propensity-Score Based Analysis of Long-Term Outcomes

Long-Term Outcome After Resection of Hepatic and Pulmonary Metastases in Multivisceral Colorectal Cancer

Combined Hepatic Resection and Radio-frequency Ablation for Patients with Colorectal Cancer Liver Metastasis: A Viable Option for Patients with a Large Number of Tumors

Liver Venous Deprivation for Rapid Liver Hypertrophy Before Major Hepatectomy: A Case Report

Novel liver vein deprivation technique that promotes increased residual liver volume (with video): A case report

Laparoscopic versus open right hepatectomy for colorectal liver metastases after portal vein embolization: international multicentre study

Oncological Outcomes of Major Liver Resection Following Portal Vein Embolization: A Systematic Review and Meta-analysis

Boosted-Dose Yttrium-90 Radiation Segmentectomy or Lobectomy for Hepatocellular Carcinoma Refractory to Prior Transarterial Embolization or Chemoembolization: A Single Institution Retrospective Case Series

Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical trial (COLDFIRE-2 trial)

The effect of preoperative chemotherapy on liver regeneration after portal vein embolization/ligation or liver resection in patients with colorectal liver metastasis: a systematic review protocol

[Standard surgical resection of colorectal liver metastases]

Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy for Colorectal Liver Metastasis: a Single-Center Experience